Clinical trial
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin…
NCT00439946 · United Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00439946 |
|---|---|
| Title | Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH |
| Official title | Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) Using the Crono Five Ambulatory Infusion Pump in Patients With Stable Pulmonary Arterial Hypertension (PAH): Safety, Efficacy and Treatment Satisfaction |
| Lead sponsor | United Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension |
| Intervention type | Device, Drug |
| Interventions | treprostinil, Crono Five ambulatory pump |
| Enrollment | 8 |
| Start date | Feb 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Mar 1, 2011 |
| First posted | Feb 26, 2007 |
| Last update posted | Jan 3, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: